End-of-day quote
Other stock markets
|
||
- GBX | - |
05-17 | UK's FTSE 100 Closes Lower Amid Inflation Focus | MT |
05-17 | Marti Technologies Hires Oguz Erkan as CFO | MT |
Sales 2024 * | 31.63B 40.17B 54.67B | Sales 2025 * | 33.58B 42.65B 58.05B | Capitalization | 72.39B 91.93B 125B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 7.04B 9.58B | Net income 2025 * | 6.49B 8.25B 11.23B | EV / Sales 2024 * | 2.68 x |
Net Debt 2024 * | 12.29B 15.6B 21.24B | Net Debt 2025 * | 9.07B 11.52B 15.67B | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.2
x | Employees | - |
Yield 2024 * |
3.43% | Yield 2025 * |
3.56% | Free-Float | 94.54% |
Latest transcript on GlaxoSmithKline plc
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |